We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
KBR to Work With Chevron Lummus Global for India Project
Read MoreHide Full Article
KBR, Inc.’s (KBR - Free Report) market-leading technology — ROSE solvent de-asphalting (“SDA”) process — is all set to be integrated with Chevron Lummus Global’s (“CLG”) LC-MAX technology to support Hindustan Petroleum Corporation Limited’s (“HPCL”) modernization project at the Visakh refinery in India.
Contract Synergies
Per the contract, KBR will provide technology licensing as well as basic engineering design and proprietary equipment services for the ROSE SDA portion of the LC-MAX unit. Notably, ROSE is a cost-effective solution that upgrades larger proportion of low-value residue streams into high-value products. Also, the solution enables clients to develop the underlying market in fuel, lube and petrochemical applications. It also helps them reduce environmental footprint of their products.
The collaboration with the LC-MAX technology — an advanced, patented, ebullated-bed residue upgrading process — will be a significant economic solution. This will enhance KBR’s Technology Solutions’ profitability. The company has already been awarded more than 60 ROSE licenses with a combined licensed capacity of nearly 1.6 million BPSD that includes many repeat licensees.
Technology Solutions Bodes Well
Refining and petrochemicals projects in India as well as higher technologies demand continue to drive the Technology Solutions segment. Notably, the segment’s revenues increased 18.5% year over year in the third quarter of 2019.
During the third quarter, the company received a Purifier license and basic engineering design contract for the largest grassroots ammonia plant designed by KBR. The plant featured energy efficiency, flexibility and lower capital costs.
The Technology Solutions segment recorded 48%, 29% and 19% organic growth in the first, the second and the third quarter of 2019, respectively. The results were primarily backed by strong execution across its chemical, petrochemical, refining and ammonia projects as well as increased proprietary equipment sales. The company expects global technology opportunities led by ammonia, refining and olefins projects to continue.
Courtesy of robust contribution from the company’s businesses, shares of KBR have surged 98.9% so far this year compared with the industry’s 27.1% rally.
Some better-ranked stocks in the same industry are Gates Industrial Corporation plc (GTES - Free Report) , Quanta Services, Inc (PWR - Free Report) , and AECOM (ACM - Free Report) . Gates and Quanta Services sport a Zack Rank #1(Strong Buy), while AECOM carries a Zacks Rank #2 (Buy).
Gates Industrial’s earnings surpassed estimates in two of the trailing four quarters, the average being 12.1%.
Quanta Services’ current-year earnings are expected to rise approximately 15%.
AECOM has three-five year expected earnings per share growth rate of 9.3%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
KBR to Work With Chevron Lummus Global for India Project
KBR, Inc.’s (KBR - Free Report) market-leading technology — ROSE solvent de-asphalting (“SDA”) process — is all set to be integrated with Chevron Lummus Global’s (“CLG”) LC-MAX technology to support Hindustan Petroleum Corporation Limited’s (“HPCL”) modernization project at the Visakh refinery in India.
Contract Synergies
Per the contract, KBR will provide technology licensing as well as basic engineering design and proprietary equipment services for the ROSE SDA portion of the LC-MAX unit. Notably, ROSE is a cost-effective solution that upgrades larger proportion of low-value residue streams into high-value products. Also, the solution enables clients to develop the underlying market in fuel, lube and petrochemical applications. It also helps them reduce environmental footprint of their products.
The collaboration with the LC-MAX technology — an advanced, patented, ebullated-bed residue upgrading process — will be a significant economic solution. This will enhance KBR’s Technology Solutions’ profitability. The company has already been awarded more than 60 ROSE licenses with a combined licensed capacity of nearly 1.6 million BPSD that includes many repeat licensees.
Technology Solutions Bodes Well
Refining and petrochemicals projects in India as well as higher technologies demand continue to drive the Technology Solutions segment. Notably, the segment’s revenues increased 18.5% year over year in the third quarter of 2019.
During the third quarter, the company received a Purifier license and basic engineering design contract for the largest grassroots ammonia plant designed by KBR. The plant featured energy efficiency, flexibility and lower capital costs.
The Technology Solutions segment recorded 48%, 29% and 19% organic growth in the first, the second and the third quarter of 2019, respectively. The results were primarily backed by strong execution across its chemical, petrochemical, refining and ammonia projects as well as increased proprietary equipment sales. The company expects global technology opportunities led by ammonia, refining and olefins projects to continue.
Courtesy of robust contribution from the company’s businesses, shares of KBR have surged 98.9% so far this year compared with the industry’s 27.1% rally.
Zacks Rank & Key Picks
Currently, KBR currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the same industry are Gates Industrial Corporation plc (GTES - Free Report) , Quanta Services, Inc (PWR - Free Report) , and AECOM (ACM - Free Report) . Gates and Quanta Services sport a Zack Rank #1(Strong Buy), while AECOM carries a Zacks Rank #2 (Buy).
Gates Industrial’s earnings surpassed estimates in two of the trailing four quarters, the average being 12.1%.
Quanta Services’ current-year earnings are expected to rise approximately 15%.
AECOM has three-five year expected earnings per share growth rate of 9.3%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>